/
INM
$1.57+$0.03 (+1.95%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$5.1M
3M shares
52-week range
$0.58 – $3.35
36% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Price (6 mo)
Loading chart…
Change$-1588.43
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $1.1M | $4.1M | $4.6M | $4.9M |
| Cost of revenue | $122.9K | $123.2K | $183.1K | $0 | $545.9K | $2.7M | $3.5M | $3.2M |
| Gross profit | −$122.9K | −$123.2K | −$183.1K | $0 | $543.5K | $1.4M | $1.1M | $1.7M |
| Gross margin | — | — | — | — | 49.9% | 33.9% | 23.9% | 34.5% |
| R&D | $2.0M | $4.3M | $5.8M | $6.6M | $7.3M | $3.7M | $3.2M | $2.9M |
| Operating income | −$9.0M | −$13.5M | −$9.2M | −$12.2M | −$13.8M | −$8.4M | −$8.1M | −$7.9M |
| EBITDA | −$8.9M | −$10.3M | −$8.8M | −$12.2M | −$18.1M | −$7.3M | −$7.1M | −$7.3M |
| Net income | −$8.9M | −$10.0M | −$8.9M | −$12.6M | −$18.6M | −$7.9M | −$7.7M | −$8.2M |
| Net margin | — | — | — | — | -1707.3% | -192.2% | -166.9% | -165.1% |
| EPS (diluted) | -1032.12 | -1264.97 | -1161.21 | -938.91 | -16582.00 | -64.92 | -20.14 | -8.36 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $71M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
InMed Pharmaceuticals Inc. Common Shares
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
www.inmedpharma.com- Employees
- 13
- IPO / List date
- Nov 10, 2020
- HQ
- VANCOUVER, A1
Held by traders on TradeandTell
No one on the platform currently holds INM.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-09-30 | 16,800 | $36.8K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-11-14 | 1-for-20reverse |
| 2022-09-07 | 1-for-25reverse |
Recent trades on TradeandTell
No one on the platform has traded INM yet.
